Loading

Examining Innovative Business Models for Creating Sustainable Network and Capabilities for Public Health and Biosecurity Countermeasures

June 16, 2025
Breakout Session
Business Development and Investment
206AB
As biological threats evolve, traditional stockpiling strategies need to adapt to ensure both readiness and flexibility. This session will delve into dual-use models that serve commercial and public health needs, enhancing resource optimization and resilience. By also linking low-demand public health items with higher-demand commercial products, these dual-use models can drive commercial sustainability while expanding access to unmet medical needs. Participants will gain insights into how these models can create growth in reaching underserved medical areas, foster resilience, and support rapid, coordinated responses to biosecurity challenges, ultimately strengthening global health security.

Keywords

Innovative Business Models, Sustainable Networks, Biosecurity
Moderator
Emma Wheatley, JD
Executive Director Access and Business Development
CEPI
Speakers
Glenn Rockman
Founder and Managing Partner
Adjuvant Global Health Technology Fund
Derrick Sim, MD
Managing Director of Vaccine Markets, Health Security & COVAX
GAVI The Vaccine Alliance
Lynda Stuart, MD, PhD
President and Chief Executive Officer
Fund for Science and Technology Washington
Rajinder Kumar Suri, MS
CEO
Developing Countries Vaccine Manufacturers Network (DCVMN) International
Back to Session List

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

BIO HELIX SPONSORS